UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 245

Sortiert nach

Hommages à Pierre-Marie Martin

Oncologie (Paris, France), 2019-01, Vol.21 (1-4), p.1-2

2019

Volltextzugriff (PDF)

Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4053-4059

2000

Volltextzugriff (PDF)

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction

Endocrine-related cancer, 2004-09, Vol.11 (3), p.489-495

2004

Volltextzugriff (PDF)

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

Clinical cancer research, 2000-08, Vol.6 (8), p.3117-3122

2000

Volltextzugriff (PDF)

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-α-initiated apoptosis

British journal of cancer, 1998-04, Vol.77 (7), p.1103-1107

1998

Volltextzugriff (PDF)

The resistance of B-CLL cells to DNA damage–induced apoptosis defined by DNA microarrays

Blood, 2003-06, Vol.101 (11), p.4598-4606

2003

Volltextzugriff (PDF)

High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases

Histopathology, 2000-12, Vol.37 (6), p.536-545

2000

Volltextzugriff (PDF)

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (2), p.116-128

2002

Volltextzugriff (PDF)

Increased sensitivity of CLL‐derived lymphocytes to apoptotic death activation by the proteasome‐specific inhibitor lactacystin

British journal of haematology, 1999-06, Vol.105 (3), p.752-757

1999

Volltextzugriff (PDF)

Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

Clinical cancer research, 2004-02, Vol.10 (4), p.1392-1400

2004

Volltextzugriff (PDF)

Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens

Endocrine-related cancer, 2003-09, Vol.10 (3), p.409-418

2003

Volltextzugriff (PDF)

Sequential assessment of multidrug resistance phenotype and measurement of S‐phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy

Cancer, 1996-01, Vol.77 (2), p.292-300

1996

Volltextzugriff (PDF)

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

British journal of cancer, 2003-08, Vol.89 (3), p.539-545

2003

Volltextzugriff (PDF)

Age as prognostic factor in premenopausal breast carcinoma

The Lancet (British edition), 1993-04, Vol.341 (8852), p.1039-1043

1993

Volltextzugriff (PDF)

Caractéristiques biologiques pré– et post–traitementnéo–adjuvant du cancer du sein

Oncologie (Paris, France), 2004, Vol.6 (3), p.175-180

Magdelénat, H.

2004

Volltextzugriff (PDF)

Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy

JNCI : Journal of the National Cancer Institute, 1989-09, Vol.81 (18), p.1383-1387

1989

Volltextzugriff (PDF)

Ubiquitin-Proteasome System and Increased Sensitivity of B-CLL Lymphocytes to Apoptotic Death Activation

Leukemia & lymphoma, 2000-08, Vol.38 (5-6), p.499-504

2000

Volltextzugriff (PDF)

Phytoestrogens after breast cancer

Endocrine-related cancer, 2001-06, Vol.8 (2), p.129-134

2001

Volltextzugriff (PDF)

Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast

Histopathology, 2004-08, Vol.45 (2), p.142-147

2004

Volltextzugriff (PDF)

Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis

International journal of cancer, 1992-02, Vol.50 (4), p.533-538

1992

Volltextzugriff (PDF)

Tumour markers in oncology: past, present and future

Journal of immunological methods, 1992-06, Vol.150 (1), p.133-143

MAGDELENAT, H

1992

Volltextzugriff (PDF)

p53 Mutation as a Genetic Trait of Typical Medullary Breast Carcinoma

JNCI : Journal of the National Cancer Institute, 1999-04, Vol.91 (7), p.641-643

1999

Volltextzugriff (PDF)

A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas

Neurosurgery, 1996-09, Vol.39 (3), p.478-483

1996

Volltextzugriff (PDF)

The Receptor and Biomarker Study Group of the EORTC

The International journal of biological markers, 2000-01, Vol.15 (1), p.61-61

Magdelénat, H.

2000

Volltextzugriff (PDF)

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

British journal of cancer, 1996-06, Vol.73 (12), p.1545-1551

1996

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hommages à Pierre-Marie Martin

Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-α-initiated apoptosis

The resistance of B-CLL cells to DNA damage–induced apoptosis defined by DNA microarrays

High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Increased sensitivity of CLL‐derived lymphocytes to apoptotic death activation by the proteasome‐specific inhibitor lactacystin

Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens

Sequential assessment of multidrug resistance phenotype and measurement of S‐phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

Age as prognostic factor in premenopausal breast carcinoma

Caractéristiques biologiques pré– et post–traitementnéo–adjuvant du cancer du sein

Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy

Ubiquitin-Proteasome System and Increased Sensitivity of B-CLL Lymphocytes to Apoptotic Death Activation

Phytoestrogens after breast cancer

Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast

Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis

Tumour markers in oncology: past, present and future

p53 Mutation as a Genetic Trait of Typical Medullary Breast Carcinoma

A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas

The Receptor and Biomarker Study Group of the EORTC

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

Suchergebnisse filtern